10th Mar 2022
DIOSynVax, led by Professor Jonathan Heeney, Head of the Laboratory of Viral Zoonotics, University of Cambridge, and our CSAR speaker on 21st Feb. 2022, will design and select the lead antigen through proof-of-concept preclinical studies, and undertake initial clinical development through Phase I/II studies.
Read more